Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
138.7 USD | -0.56% | +3.97% | +11.77% |
Kurzporträt
Die Vereinigten Staaten machen 72,5% des Nettoumsatzes aus.
Mitarbeiterzahl: 9 550
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Distributor
85,5
%
| 2 471 | 84,9 % | 3 096 | 85,5 % | +25.29% |
Direct
14,5
%
| 439 | 15,1 % | 527 | 14,5 % | +19.98% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
72,5
%
| 2 142 | 73,6 % | 2 625 | 72,5 % | +22.56% |
International
27,5
%
| 768 | 26,4 % | 997 | 27,5 % | +29.85% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01.11.07 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 01.09.18 |
Chief Tech/Sci/R&D Officer | 47 | 01.10.22 | |
Shelly Selvaraj
CTO | Chief Tech/Sci/R&D Officer | 65 | 01.05.16 |
Jacob Leach
COO | Chief Operating Officer | 46 | 01.03.04 |
Donald Abbey
CTO | Chief Tech/Sci/R&D Officer | 57 | 01.05.16 |
Andrew Balo
CTO | Chief Tech/Sci/R&D Officer | 76 | 01.02.02 |
Sean Christensen
IRC | Investor Relations Contact | - | - |
Paul Flynn
PRN | Corporate Officer/Principal | 55 | 01.10.15 |
Sadie Stern
HRO | Human Resources Officer | 49 | 01.09.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 20.11.09 |
Mark Foletta
BRD | Director/Board Member | 63 | 19.11.14 |
Eric Topol
BRD | Director/Board Member | 69 | 09.07.09 |
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01.11.07 |
Steven Altman
BRD | Director/Board Member | 62 | 07.11.13 |
Bridgette Heller
BRD | Director/Board Member | 63 | 13.09.19 |
Richard Collins
BRD | Director/Board Member | 67 | 09.03.17 |
Kyle Malady
BRD | Director/Board Member | 56 | 11.10.20 |
Barbara Kahn
BRD | Director/Board Member | 71 | 01.04.11 |
Karen Dahut
BRD | Director/Board Member | 60 | 11.08.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 407 315 421 | 383 801 360 ( 94,23 %) | 21 800 000 ( 5,352 %) | 94,23 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Dexcom Operating Ltd.
Dexcom Operating Ltd. Financial ConglomeratesFinance Part of DexCom, Inc., DexCom Operating Ltd. functions as an investment holding British company. The private company is based in Reading, UK and was founded in 2015. |
Financial Conglomerates
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+11.77% | 53.47 Mrd. | |
+3.26% | 197 Mrd. | |
+5.79% | 116 Mrd. | |
+1.48% | 71.49 Mrd. | |
+18.31% | 48.42 Mrd. | |
+6.33% | 43.64 Mrd. | |
+12.38% | 28.97 Mrd. | |
+9.76% | 28.47 Mrd. | |
+10.35% | 27.78 Mrd. | |
+18.09% | 27.08 Mrd. |
- Börse
- Aktien
- Aktie DexCom, Inc. - Nasdaq
- Unternehmen DexCom, Inc.